Qube Research & Technologies (QRT)’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-8,809,340
| Closed | -$127M | – | 3682 |
|
|
2026
Q1 | $127M | Buy |
8,809,340
+4,374,661
| +99% | +$62.7M | 0.14% | 166 |
|
|
2025
Q4 | $63.1M | Buy |
4,434,679
+2,685,100
| +153% | +$26.4M | 0.06% | 393 |
|
|
2025
Q3 | $13.8M | Sell |
1,749,579
-1,717,332
| -50% | -$12.2M | 0.01% | 1118 |
|
|
2025
Q2 | $19.9M | Buy |
3,466,911
+2,396,410
| +224% | +$15.5M | 0.02% | 885 |
|
|
2025
Q1 | $8.74M | Buy |
1,070,501
+267,423
| +33% | +$2.47M | 0.01% | 1219 |
|
|
2024
Q4 | $7.56M | Buy |
803,078
+112,160
| +16% | +$1.17M | 0.01% | 1263 |
|
|
2024
Q3 | $7.38M | Buy |
690,918
+629,928
| +1,033% | +$6.86M | 0.01% | 1213 |
|
|
2024
Q2 | $605K | Sell |
60,990
-495,373
| -89% | -$5.08M | ﹤0.01% | 2083 |
|
|
2024
Q1 | $6.55M | Buy |
+556,363
| New | +$7.12M | 0.01% | 1065 |
|
|
2023
Q2 | – | Sell |
-204,119
| Closed | -$2.26M | – | 2592 |
|
|
2023
Q1 | $2.26M | Buy |
204,119
+139,829
| +217% | +$1.72M | 0.01% | 954 |
|
|
2022
Q4 | $785K | Sell |
64,290
-5,779
| -8% | -$65.1K | ﹤0.01% | 1322 |
|
|
2022
Q3 | $732K | Buy |
+70,069
| New | +$781K | ﹤0.01% | 1317 |
|
|
2021
Q4 | – | Sell |
-35,568
| Closed | -$340K | – | 2666 |
|
|
2021
Q3 | $340K | Buy |
35,568
+21,119
| +146% | +$216K | ﹤0.01% | 1431 |
|
|
2021
Q2 | $139K | Sell |
14,449
-11,690
| -45% | -$114K | ﹤0.01% | 1878 |
|
|
2021
Q1 | $258K | Buy |
+26,139
| New | +$405K | ﹤0.01% | 1530 |
|
|
2020
Q4 | – | Sell |
-30,658
| Closed | -$433K | – | 1943 |
|
|
2020
Q3 | $433K | Buy |
30,658
+20,344
| +197% | +$297K | 0.01% | 1097 |
|
|
2020
Q2 | $156K | Buy |
+10,314
| New | +$126K | ﹤0.01% | 1462 |
|
Other funds holding FOLD
Qube Research & Technologies (QRT)'s FOLD Position: Q2 2026 in Review
Qube Research & Technologies (QRT) sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 8,809,340 shares — an estimated $127M sold.
Qube Research & Technologies (QRT) first reported a position in FOLD in Q2 2020 and held it in 17 quarters. The position peaked at $127M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.
- Qube Research & Technologies (QRT) reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 8,809,340 Amicus Therapeutics shares in Q2 2026, an estimated $127M.
- Qube Research & Technologies (QRT) first reported a position in Amicus Therapeutics in Q2 2020 and held it in 17 quarters.
- Qube Research & Technologies (QRT)'s Amicus Therapeutics position peaked at $127M in Q1 2026.
- 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.